The artificial organ and bionics market size has grown rapidly in recent years. It will grow from $35.86 billion in 2025 to $40.03 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising organ transplant shortages, advancements in biomedical engineering, expansion of prosthetics adoption, increasing survival rates of chronic disease patients, improvements in surgical implantation techniques.
The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $63.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biohybrid organ research, rising demand for intelligent bionic systems, expansion of brain-computer interface applications, growing focus on quality-of-life enhancement, technological convergence in organ replacement therapies. Major trends in the forecast period include increasing development of advanced artificial organs, rising adoption of bionic limbs and exoskeletons, growing integration of neural interface technologies, expansion of implantable life-support devices, enhanced focus on long-term organ replacement solutions.
The rising number of transplants is expected to drive the growth of the artificial organ and bionics market in the coming years. Transplantation refers to a surgical procedure in humans or animals in which an organ or tissue is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace a damaged organ and perform specific functions of the natural organ, enabling patients to maintain a quality of life similar to normal conditions. For example, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific and educational organization, the United States recorded 48,149 organ transplants in 2024, exceeding 48,000 and representing a 3.3% increase compared to 2023. Of these procedures, 41,119 transplants were from deceased donors, while 7,030 were from living donors. Therefore, the increasing number of transplants is driving the growth of the artificial organ and bionics market.
Major companies active in the artificial organs and bionics market are prioritizing advanced technological innovations, including microprocessor-controlled prosthetic knees, to improve mobility and enable more natural, intuitive movement for individuals with lower-limb amputations. These prosthetic knees use integrated sensors and onboard processors to continuously adjust to a user’s walking pattern in real time. For example, in January 2025, BionicM, a Japan-based startup and spin-off from the University of Tokyo specializing in robotics and prosthetics, introduced its Bio Leg in the U.S. market. This powered knee, named a CES 2025 Best of Innovation award winner, uses robotic technology to compensate for lost muscle function, delivering smoother motion, greater safety, and an improved quality of life for amputees.
In November 2024, OrganOx Ltd, a UK-based organ technology company focused on normothermic perfusion systems for donor organs, entered into a partnership with eGenesis to clinically co-develop an organ support therapy. This initiative combines OrganOx’s perfusion platform with genetically engineered porcine livers to address acute liver failure. Through this collaboration, OrganOx seeks to strengthen its position in the artificial organ and bionics market by enabling a novel biologically engineered liver support solution that can enhance patient outcomes and broaden access to organ replacement therapies.
Major companies operating in the artificial organ and bionics market are Abiomed Inc., Asahi Kasei Medical Co. Ltd, Baxter, Berlin Heart GmbH, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Nano Retina Ltd, Edwards Lifesciences Corporation, Sonova, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc., St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd.
North America was the largest region in the artificial organ and bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organ and bionics market by increasing costs of imported electronic components, sensors, actuators, biocompatible materials, and precision manufacturing equipment. Healthcare systems in North America and Europe are most affected due to dependence on advanced imported components, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and extending development timelines. At the same time, they are encouraging domestic innovation, localized production capabilities, and strategic investments in next-generation artificial organ technologies.
The artificial organ and bionics market research report is one of a series of new reports that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with a artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.
Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.
The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $63.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biohybrid organ research, rising demand for intelligent bionic systems, expansion of brain-computer interface applications, growing focus on quality-of-life enhancement, technological convergence in organ replacement therapies. Major trends in the forecast period include increasing development of advanced artificial organs, rising adoption of bionic limbs and exoskeletons, growing integration of neural interface technologies, expansion of implantable life-support devices, enhanced focus on long-term organ replacement solutions.
The rising number of transplants is expected to drive the growth of the artificial organ and bionics market in the coming years. Transplantation refers to a surgical procedure in humans or animals in which an organ or tissue is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace a damaged organ and perform specific functions of the natural organ, enabling patients to maintain a quality of life similar to normal conditions. For example, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific and educational organization, the United States recorded 48,149 organ transplants in 2024, exceeding 48,000 and representing a 3.3% increase compared to 2023. Of these procedures, 41,119 transplants were from deceased donors, while 7,030 were from living donors. Therefore, the increasing number of transplants is driving the growth of the artificial organ and bionics market.
Major companies active in the artificial organs and bionics market are prioritizing advanced technological innovations, including microprocessor-controlled prosthetic knees, to improve mobility and enable more natural, intuitive movement for individuals with lower-limb amputations. These prosthetic knees use integrated sensors and onboard processors to continuously adjust to a user’s walking pattern in real time. For example, in January 2025, BionicM, a Japan-based startup and spin-off from the University of Tokyo specializing in robotics and prosthetics, introduced its Bio Leg in the U.S. market. This powered knee, named a CES 2025 Best of Innovation award winner, uses robotic technology to compensate for lost muscle function, delivering smoother motion, greater safety, and an improved quality of life for amputees.
In November 2024, OrganOx Ltd, a UK-based organ technology company focused on normothermic perfusion systems for donor organs, entered into a partnership with eGenesis to clinically co-develop an organ support therapy. This initiative combines OrganOx’s perfusion platform with genetically engineered porcine livers to address acute liver failure. Through this collaboration, OrganOx seeks to strengthen its position in the artificial organ and bionics market by enabling a novel biologically engineered liver support solution that can enhance patient outcomes and broaden access to organ replacement therapies.
Major companies operating in the artificial organ and bionics market are Abiomed Inc., Asahi Kasei Medical Co. Ltd, Baxter, Berlin Heart GmbH, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Nano Retina Ltd, Edwards Lifesciences Corporation, Sonova, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc., St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd.
North America was the largest region in the artificial organ and bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organ and bionics market by increasing costs of imported electronic components, sensors, actuators, biocompatible materials, and precision manufacturing equipment. Healthcare systems in North America and Europe are most affected due to dependence on advanced imported components, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and extending development timelines. At the same time, they are encouraging domestic innovation, localized production capabilities, and strategic investments in next-generation artificial organ technologies.
The artificial organ and bionics market research report is one of a series of new reports that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with a artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.
Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.
The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Organ and Bionics Market Characteristics
3. Artificial Organ and Bionics Market Supply Chain Analysis
4. Global Artificial Organ and Bionics Market Trends and Strategies
5. Artificial Organ and Bionics Market Analysis of End Use Industries
7. Global Artificial Organ and Bionics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Organ and Bionics Total Addressable Market (TAM) Analysis for the Market
9. Artificial Organ and Bionics Market Segmentation
10. Artificial Organ and Bionics Market Regional and Country Analysis
11. Asia-Pacific Artificial Organ and Bionics Market
12. China Artificial Organ and Bionics Market
13. India Artificial Organ and Bionics Market
14. Japan Artificial Organ and Bionics Market
15. Australia Artificial Organ and Bionics Market
16. Indonesia Artificial Organ and Bionics Market
17. South Korea Artificial Organ and Bionics Market
18. Taiwan Artificial Organ and Bionics Market
19. South East Asia Artificial Organ and Bionics Market
20. Western Europe Artificial Organ and Bionics Market
21. UK Artificial Organ and Bionics Market
22. Germany Artificial Organ and Bionics Market
23. France Artificial Organ and Bionics Market
24. Italy Artificial Organ and Bionics Market
25. Spain Artificial Organ and Bionics Market
26. Eastern Europe Artificial Organ and Bionics Market
27. Russia Artificial Organ and Bionics Market
28. North America Artificial Organ and Bionics Market
29. USA Artificial Organ and Bionics Market
30. Canada Artificial Organ and Bionics Market
31. South America Artificial Organ and Bionics Market
32. Brazil Artificial Organ and Bionics Market
33. Middle East Artificial Organ and Bionics Market
34. Africa Artificial Organ and Bionics Market
36. Artificial Organ and Bionics Market Competitive Landscape and Company Profiles
37. Artificial Organ and Bionics Market Other Major and Innovative Companies
40. Artificial Organ and Bionics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Organ And Bionics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial organ and bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial organ and bionics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ and bionics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Artificial Organs; Artificial Bionics2) By Fixation Type: Implantable Artificial Organs and Bionics; Externally Worn Artificial Organs and Bionics; Hybrid Systems
3) By Technology: Mechanical Bionics; Electronic Bionics
Subsegments:
1) By Artificial Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas; Artificial Lungs2) By Artificial Bionics: Bionic Limbs; Bionic Eyes; Exoskeletons; Neural Prosthetics
Companies Mentioned: Abiomed Inc.; Asahi Kasei Medical Co. Ltd; Baxter; Berlin Heart GmbH; Cyberonics Inc.; Ekso Bionics Holdings Inc.; Getinge AB; Medtronic PLC; Bornlife Prosthetic and Orthotic Inc.; Nano Retina Ltd; Edwards Lifesciences Corporation; Sonova; Cochlear Limited; Advanced Bionics AG; Ottobock SE & Co. KGaA; Second Sight Medical Products Inc.; iWalk Inc.; Jarvik Heart Inc.; St. Jude Medical Inc.; Harmonic Bionics Inc.; Open Bionics; Beta Bionics Inc.; Bionic Prosthetics and Orthotics; Mobius Bionics; Touch Bionics Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Organ and Bionics market report include:- Abiomed Inc.
- Asahi Kasei Medical Co. Ltd
- Baxter
- Berlin Heart GmbH
- Cyberonics Inc.
- Ekso Bionics Holdings Inc.
- Getinge AB
- Medtronic PLC
- Bornlife Prosthetic and Orthotic Inc.
- Nano Retina Ltd
- Edwards Lifesciences Corporation
- Sonova
- Cochlear Limited
- Advanced Bionics AG
- Ottobock SE & Co. KGaA
- Second Sight Medical Products Inc.
- iWalk Inc.
- Jarvik Heart Inc.
- St. Jude Medical Inc.
- Harmonic Bionics Inc.
- Open Bionics
- Beta Bionics Inc.
- Bionic Prosthetics and Orthotics
- Mobius Bionics
- Touch Bionics Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 40.03 Billion |
| Forecasted Market Value ( USD | $ 63.1 Billion |
| Compound Annual Growth Rate | 12.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
